Idiopathic pulmonary fibrosis is a potentially lethal disease for which there is currently no cure and that is associated with certain mutations or advanced age. The Telomeres and Telomerase Group at the Spanish National ...
Aug 10, 2020
0
3
(Medical Xpress) -- Researchers at the University of Liverpool are examining the evolution of Pseudomonas aeruginosa over time in the lungs of ten people with cystic fibrosis to understand why it persists in these patients ...
Mar 6, 2012
0
0
Doctors have hoped that antibiotics could benefit patients with chronic lung diseases, but a new study has found no benefit for patients with life-threatening idiopathic pulmonary fibrosis in preventing hospitalization or ...
Jun 2, 2021
0
6
Patients with severe COVID-19 disease have significantly shorter telomeres, according to a study conducted by researchers at the Spanish National Cancer Research Centre (CNIO) in collaboration with the COVID-IFEMA Field Hospital, ...
Jan 11, 2021
0
25
Researchers in Japan have identified a genetic mutation that causes a severe lung disease called idiopathic pulmonary fibrosis (IPF) by killing the cells lining the lung's airways. The study, which will be published October ...
Oct 10, 2019
0
5
Researchers from the University of Copenhagen have shown for the first time how bacteria can grow directly in the lungs of Cystic fibrosis patients, giving them the opportunity to get tremendous insights into bacteria behavior ...
Oct 18, 2014
0
0
Cystic fibrosis (CF), a chronic disease that clogs the lungs and leads to life-threatening lung infections, is caused by a genetic defect in a chloride channel called cystic fibrosis transmembrane conductase regulator (CFTR). ...
Sep 19, 2011
0
0
The five-year survival rate for Canadians with cystic fibrosis who have received a lung transplant is 67 per cent and half of those who have had transplants live beyond 10 years, new research has found.
Jun 15, 2015
0
135
Researchers at Boston Children's Hospital and Brigham and Women's Hospital have launched a randomized, placebo-controlled clinical trial of dornase alfa (Pulmozyme) in patients with severe COVID-19 pneumonia and respiratory ...
Jul 28, 2020
0
6
Working alongside research groups from Heidelberg, researchers from Charité - Universitätsmedizin Berlin have elucidated the novel disease processes involved in the development of pulmonary fibrosis. They were able to show ...
Apr 27, 2020
0
10
